Serum prostate-specific antigen as a predictor of prostate volume in Korean men with lower urinary tract symptoms

被引:0
作者
H B Shim
J K Lee
T Y Jung
J H Ku
机构
[1] Seoul Veterans Hospital,Department of Urology
来源
Prostate Cancer and Prostatic Diseases | 2007年 / 10卷
关键词
prostate-specific antigen; prostate volume; prostatic hyperplasia;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study was to assess the utility of prostate-specific antigen (PSA) as a predictor of prostate volume indexes (total prostate volume (TPV), transition zone volume and transition zone index) in Korean men with lower urinary tract symptoms (LUTS). From September 2003 to April 2006, 3431 patients with LUTS were included in the study; they had a median age of 63.8 years, a median prostate volume of 22.6 ml and a median serum PSA of 1.04 ng/ml. Men with a baseline PSA of >10 ng/ml were excluded, to reduce the likelihood of including occult prostate cancer. Prostate volume indexes and serum PSA levels had an age-dependent log-linear relationship. Receiver operating characteristic curve analysis showed that PSA had good predictive value for various prostate volume indexes thresholds. The approximate age-specific criteria for detecting men with a TPV of >40 ml are PSA levels of 1.20, 1.44 and 1.72 ng/ml for men with LUTS in their sixth, seventh and eighth decades, respectively. The results show that serum PSA identifies Korean men with large prostates reasonably well. Korean men may produce and/or release more PSA per unit prostate volume than white men. The cutoffs for PSA and prostate volume to response to LUTS therapy should be determined in this population.
引用
收藏
页码:143 / 148
页数:5
相关论文
共 96 条
[1]  
Boyle P(1996)Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials Urology 48 398-405
[2]  
Gould AL(1997)Natural history of prostatism: risk factors for acute urinary retention J Urol 158 481-487
[3]  
Roehrborn CG(1999)Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group Urology 53 473-480
[4]  
Jacobsen SJ(1998)The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group N Engl J Med 338 557-563
[5]  
Jacobsen DJ(2003)Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study Eur Urol 44 94-99
[6]  
Girman CJ(1999)Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Urology 53 581-589
[7]  
Roberts RO(1999)Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia Drugs 57 557-581
[8]  
Rhodes T(1997)Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound Urology 49 548-557
[9]  
Guess HA(2005)Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer Urology 66 819-823
[10]  
Roehrborn CG(2003)Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia Eur Urol 44 695-700